TR200000958T2 - Hiperglisemi tedavisinde tiazolidinedion kullanımı. - Google Patents

Hiperglisemi tedavisinde tiazolidinedion kullanımı.

Info

Publication number
TR200000958T2
TR200000958T2 TR2000/00958T TR200000958T TR200000958T2 TR 200000958 T2 TR200000958 T2 TR 200000958T2 TR 2000/00958 T TR2000/00958 T TR 2000/00958T TR 200000958 T TR200000958 T TR 200000958T TR 200000958 T2 TR200000958 T2 TR 200000958T2
Authority
TR
Turkey
Prior art keywords
hyperglycemia
thiazolidinedione
treatment
mammal
toxic
Prior art date
Application number
TR2000/00958T
Other languages
English (en)
Turkish (tr)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000958T2 publication Critical patent/TR200000958T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2000/00958T 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı. TR200000958T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
TR200000958T2 true TR200000958T2 (tr) 2000-08-21

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00958T TR200000958T2 (tr) 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı.

Country Status (24)

Country Link
EP (1) EP1023056A1 (fr)
JP (1) JP2001519382A (fr)
KR (1) KR20010024481A (fr)
CN (1) CN1281359A (fr)
AP (1) AP2000001787A0 (fr)
AU (1) AU9547098A (fr)
BG (1) BG104404A (fr)
BR (1) BR9815219A (fr)
CA (1) CA2306086A1 (fr)
CZ (1) CZ20001297A3 (fr)
EA (1) EA002659B1 (fr)
GB (1) GB9721693D0 (fr)
HR (1) HRP20000255A2 (fr)
HU (1) HUP0003922A3 (fr)
ID (1) ID24521A (fr)
IL (1) IL135513A0 (fr)
NO (1) NO20001898L (fr)
NZ (1) NZ503862A (fr)
OA (1) OA11683A (fr)
PL (1) PL339813A1 (fr)
SK (1) SK5312000A3 (fr)
TR (1) TR200000958T2 (fr)
WO (1) WO1999018943A1 (fr)
YU (1) YU28800A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (fr) * 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
HRP20000255A2 (en) 2001-02-28
YU28800A (sh) 2003-02-28
HUP0003922A3 (en) 2001-12-28
IL135513A0 (en) 2001-05-20
CZ20001297A3 (cs) 2001-08-15
NO20001898L (no) 2000-06-09
NO20001898D0 (no) 2000-04-12
JP2001519382A (ja) 2001-10-23
CN1281359A (zh) 2001-01-24
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
NZ503862A (en) 2003-01-31
ID24521A (id) 2000-07-20
SK5312000A3 (en) 2000-09-12
WO1999018943A1 (fr) 1999-04-22
AU9547098A (en) 1999-05-03
BG104404A (bg) 2000-12-29
PL339813A1 (en) 2001-01-02
BR9815219A (pt) 2001-01-02
EA002659B1 (ru) 2002-08-29
EA200000419A1 (ru) 2000-10-30
HUP0003922A2 (hu) 2001-10-28
CA2306086A1 (fr) 1999-04-22
EP1023056A1 (fr) 2000-08-02
OA11683A (en) 2005-01-12
KR20010024481A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
EA200101089A1 (ru) Новый способ лечения
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
MXPA03003870A (es) Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
EA200300026A1 (ru) Аналоги глюкагоноподобного пептида-1
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
TR199902033T2 (xx) Diyabet i�in s�lfonilura-glitazon sinerjik kombinasyonlar�.
TR200101174T2 (tr) Migren tedavisi için 5HT1, reseptör agonistleri ve metoklopramid.
IL143569A0 (en) A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
BR0311161A (pt) Método de tratamento de diabetes
NO20083276L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
CY1107745T1 (el) Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια
TR199903095T2 (xx) Diabetin roziglitazon ve ins�lin ile tedavisi.
HK1042852A1 (zh) 增强胰岛素反应的方法
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
NO996270L (no) Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
NO20003813L (no) FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav
TR200202033T2 (tr) Epilepsi Tedavisi İçin Terkipler ve Yöntemler
AU4193800A (en) Use of tagatose to enhance key blood factors
WO2001047509A3 (fr) Procede de traitement
TR199801133T2 (xx) Tip II diyabetin tedavisi veya �nlenmesi i�in nitrik oksit (NO) sentaz inhibit�r�
UA36485A (uk) Спосіб лікування генералізованого пародонтиту